MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
Gender differences for Motor and non motor symptoms in Parkinson’s Disease among Pakistani population

S. Naureen, A. Arshad, N. Ahmad (Islamabad, Pakistan)

Epidemiology  ·  Les Muses, Level 3
1:15pm-2:45pm
Gender-dependent improvement in the survival of Parkinson’s disease patients in Finland

T. Kuusimäki, S. Kurki, J. Sipilä, H. Salminen-Mankonen, O. Carpén, V. Kaasinen (Turku, Finland)

Epidemiology  ·  Les Muses, Level 3
1:15pm-2:45pm
Genotype influences circuit compensation in Parkinson’s disease

K. Schindlbeck, A. Vo, N. Nguyen, C. Tang, M. Niethammer, V. Dhawan, V. Brandt, R. Saunders-Pullman, S. Bressman, D. Eidelberg (Manhasset, NY, USA)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD in Germany, France and Japan

L. Ramig, T. Brauer, C. Airiau, M. Fujiu-Kurachi (Boulder, CO, USA)

Non-Pharmacological Interventions  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease

L. Velzen, J. Masselink, L. Dorresteijn, K. Movig (Enschede, Netherlands)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Glymphatic system activity in Parkinson’s disease: diffusion tensor image analysis along the perivascular space (DTI‑ALPS)

JM. Kim, YJ. Bae (Seongnam, Republic of Korea)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Gray Matter Abnormalities in Parkinson’s disease: a Voxel-wise meta-analysis

XR. Xu, Q. Han, JY. Lin, L. Wang, HF. Shang (Chengdu, China)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Gray matter substrates of depression in blepharospasm

J. Yang, YB. Hou, QQ. Wei, RW. Ou, W. Song, B. Cao, HF. Shang (Chengdu, China)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Grey matter atrophy in Parkinson’s disease with long-duration response

G. Donzuso, G. Sciacca, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Gustatory Connectivity in Parkinson’s Disease Progression

H. Chatterjee, G. Elumalai, N. Sewram, N. Osakwe (Georgetown, Guyana)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
  • «Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 67
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley